Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Other financing activities (2020 - 2025)

Historic Other financing activities for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to -$539000.0.

  • Sotera Health's Other financing activities rose 1551.72% to -$539000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 297272.73%. This contributed to the annual value of -$2.3 million for FY2024, which is 2761.48% down from last year.
  • Latest data reveals that Sotera Health reported Other financing activities of -$539000.0 as of Q3 2025, which was up 1551.72% from -$789000.0 recorded in Q2 2025.
  • Over the past 5 years, Sotera Health's Other financing activities peaked at $24.5 million during Q1 2023, and registered a low of -$26.6 million during Q2 2023.
  • For the 5-year period, Sotera Health's Other financing activities averaged around -$61473.7, with its median value being -$418000.0 (2022).
  • Within the past 5 years, the most significant YoY rise in Sotera Health's Other financing activities was 595095.69% (2023), while the steepest drop was 406598.75% (2023).
  • Quarter analysis of 5 years shows Sotera Health's Other financing activities stood at $74000.0 in 2021, then plummeted by 590.54% to -$363000.0 in 2022, then skyrocketed by 525.9% to $1.5 million in 2023, then crashed by 143.47% to -$672000.0 in 2024, then grew by 19.79% to -$539000.0 in 2025.
  • Its Other financing activities stands at -$539000.0 for Q3 2025, versus -$789000.0 for Q2 2025 and -$704000.0 for Q1 2025.